Metallointercalator [Ru(dppz)2(PIP)]2+ renders BRCA wild-type triple-negative breast cancer cells hypersensitive to PARP inhibition
There is a need to improve and extend the use of clinically approved poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi), including for BRCA wild-type triple-negative breast cancer (TNBC). The demonstration that ruthenium(II) polypyridyl complex (RPC) metallointercalators can rapidly stall DNA rep...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2020
|
Online Access: | http://psasir.upm.edu.my/id/eprint/86732/1/Metallointercalator.pdf http://psasir.upm.edu.my/id/eprint/86732/ https://pubs.acs.org/doi/full/10.1021/acschembio.9b00843 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|